Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) fell 1.5% during mid-day trading on Tuesday . The stock traded as low as $16.16 and last traded at $16.54. 100,197 shares were traded during trading, a decline of 13% from the average session volume of 115,013 shares. The stock had previously closed at $16.79.
Sysmex Price Performance
The company has a debt-to-equity ratio of 0.12, a current ratio of 2.97 and a quick ratio of 2.30. The company's 50-day simple moving average is $16.92 and its 200-day simple moving average is $17.99. The stock has a market capitalization of $10.44 billion, a P/E ratio of 29.63 and a beta of 1.14.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). The firm had revenue of $958.89 million for the quarter, compared to the consensus estimate of $991.22 million. Sysmex had a return on equity of 11.81% and a net margin of 10.56%. As a group, sell-side analysts expect that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Further Reading
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access